News

The prevalence of major depressive disorder (MDD) at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation on May 5, 2024, at the American Psychiatric Association Annual Meeting in New York, New York.

Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of major depressive disorder (MDD) over 3 years, according to a poster presentation at Psych Congress 2023 in Nashville, Tennessee.

Patients with major depressive disorder (MDD) and anhedonia (MDD-ANH) may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD) as well as lower percentages of remission in the year following initial assessment, according to results from a retrospective cohort study presented via poster.

Post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and prolonged grief disorder (PGD) appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close oth

Combining certain medications or psychotherapy with transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) may decrease symptoms of major depressive disorder (MDD), though some limitations still exist, according to a review published in the Harvard Review of Psychiatry.